InvestorsHub Logo
Followers 398
Posts 26721
Boards Moderated 0
Alias Born 02/11/2016

Re: None

Friday, 10/06/2017 9:19:50 AM

Friday, October 06, 2017 9:19:50 AM

Post# of 116605
Biotech Sector is Fertile Ground for Continued Rally, New Drug Developments and Latest Collaborations
MarketNewsUpdates.com News Commentary
PALM BEACH, Florida, October 6, 2017 /PRNewswire/ --
Oppenheimer's Leah Rush Cann recently published an article on Barron's writing Biotech stocks, that still remain sharply undervalued, with an optimistic outlook that comes on the heels of the biotech sector has posted a 17.7% gain this year through September. Her opinion is that the sector is showing 'increasing strength'. The biotech rally appears to be far from over as clinical trials advance, FDA Approvals are happening quicker and new collaborations leading to multiple therapeutic benefits are taking hold.
http://www.otcmarkets.com/stock/TWMJF/news

RSII may not be listed in this article today.........but you can bet it will be soon;
RSII is a Biotech Pharmaceutical Company specializing in the development of Alternative Pain Medications. The world needs to STOP using so many OPIODS.
$$$RSII$$$